Male infertility: current status of the problem


Дәйексөз келтіру

Толық мәтін

Аннотация

The main reason of the couple infertility is the disturbances of the spermatogenesis. The main reasons of the male infertility are varicocele, inflammatory diseases of the reproductive system, hormonal disturbances and cryptorchism. It is not possible to reveal etiologic factor of the male fertility in the large share of cases. Today there are no generally recognized methods of treatment of idiopathic male infertility and his therapy is often empirical. Subsidiary reproductive technologies are very effective in the treatment of infertility but costly and invasive.

Әдебиет тізімі

  1. Wong WY, Thomas CMG, Merkus JM, et al. Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril 2000;73:435-42.
  2. Жиборев БН. Заболевания органов половой системы в патогенезе нарушений репродуктивного здоровья мужчины // Урология. 2008. № 3. С. 62-67.
  3. Siddiq FM, Sigman M. A new look at the medical management of infertility. Urol Clin North Am 2002;29:949-63.
  4. Verstoppen GR, Steeno OP. Varicocele and the pathogenesis of the associated subfertility: a review of the various theories. II. Results of surgery. Andrologia 1977;9:293-305.
  5. World Health Organization. The influence of varicocele on parameters of fertility in a large group of men presenting to infertility clinics. Fertil Steril 1992;57:1289-93.
  6. Evers JLH, Collins JA. Assessment of efficacy of varicocele repair for male subfertility: a systematic review. Lancet 2003;361:1849-52.
  7. Laven JS, Haans LC, Mali WP, et al. Effects of varicocele treatment in adolescents: a randomised study. Fertil Steril 1992;58:756-62.
  8. Ness RB, Markovic N, Carlson CL, et al. Do men become infertile after having sexually transmitted urethritis? An epidemiologic examination. Fertil Steril. 1997;68:205-13.
  9. Cunningham KA, Beagley KW. Male genital tract chlamydial infection: implications for pathology and infertility. Biol Reprod 2008;79:180-89.
  10. Mieusset R, Bujan L, Massat G, et al. Clinical and biological characteristics of infertile men with a history of cryptorchidism. Hum Reprod 1995;10:613-19.
  11. Sadeghi-Nejad H <http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Sadeghi-Nejad%20H%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus>, Oates RD <http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Oates%20RD%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus>. The Y chromosome and male infertility. Curr Opin Urol 2008;18:628-32.
  12. Cavallini G. Male idiopathic oligoasthenoteratozoospermia. Asian J Androl 2006;8:143-57.
  13. Ochendorf FR. Infections in the male genital tract and reactive oxygen species. Hum Reprod Update 1999;5:399-420.
  14. Aitken RJ, Krausz C. Oxidative stress, DNA damage and the Y chromosome. Reproduction 2001;122:497-506.
  15. McLachlan RI, Wreford NG, O'Donnel L, et al. The endocrine regulation of spermatogenesis: independent roles for testosterone and FSH. J Endocrinol 1996;148:1-9.
  16. Sanocka D, Kurpisz M. Reactive oxygen species and sperm cells. Reprod Biol Endocrinol 2004;2:12-19.
  17. Sinha Hikim AP, Swerdloff RS. Hormonal and genetic control of germ cells apoptosis in the testis. Rev Reprod 1999;4:38-47.
  18. Said TM, Paasch U, Glander HJ, et al. Role of capases in male infertility. Hum Reprod Update 2004;10:39-51.
  19. Shang XJ, Huang YF, Xiong CL, et al. Uraplasma urealyticum infection and apoptosis of spermatogenetic cells. Asian J Androl 1999;1:127-29.
  20. Chiu WW, Chamley LW. Use of antisperm antibodies in differential display Western blotting to identify sperm proteins important in fertility. Hum Reprod 2002;17:984-89.
  21. Bohring C, Krause W. Immune infertility: towards a better understanding of sperm (auto)-immunity. The value of proteomic analysis. Hum Reprod 2003;18:915-24.
  22. Koide SS, Wang L, Kamada M. Antisperm antibodies associated with infertility: properties and encoding genes of target antigens. Proc Soc Exp Biol Med 2000;224:123-32.
  23. World Health Organization. Laboratory manual for the examination of human semen and semen-cervical mucus interaction. 3rd ed. New York: Cambridge University Press 1993:43-44.
  24. Ombelet W, Bosmans E, Janssen M, et al. Semen parameters in a fertile versus subfertile population: a need for change in the interpretation of semen testing. Hum Reprod 1997;12:987-93.
  25. Purvis K, Christiansen E. Male infertility: current concepts. Ann Med 1992;24:259-72.
  26. Kruger TF, Acosta AA, Simmons KF, et al. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril 1988;49:112-17.
  27. Evers JL, Collins JA. Surgery or embolisation for varicocele in subfertile men. Cochrane Database Syst Rev 2004;(3):CD000479.
  28. Ficarro V, Cerruto MA, Liguori G, et al. Treatment of varicocele in subfertile men: the Cochrane review - a contrary opinion. Eur Urol 2006;29:258-63.
  29. Kumar R, Gautam G, Gupta MP. Drug Therapy for Idiopathic Male Infertility: Rationale Versus Evidence. J Urol. 2006;176:1307-12.
  30. Vandekerckhove P, Lilford R, Vail A, et al. Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 2000;2:CD000150.
  31. Chehval MJ, Mehan DJ. Chorionic gonadotropins in the treatment of the subfertile male. Fertil Steril 1979;31:666-68.
  32. Vandekerckhove P, Lilford R, Vail A, Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 2000;2:CD000151.
  33. Ochsendorf FR, Buhl R, Bastlein A, et al. Glutathione in spermatozoa and seminal plasma of infertile men. Hum Reprod 1998;13:353-59.
  34. Lenzi A, Culasso F, Gandini L, et al. Placebo-controlled, double blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod 1993;8:1657-62.
  35. Kessopoulou E, Powers HJ, Sharma KK, et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 1995;64:825-31.
  36. Rolf C, Cooper TG, Yeung CH, et al. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, doubleblind study. Hum Reprod 1999;14:1028-33.
  37. Lenzi A, Sgro P, Salacone P, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004; 81: 1578-1574.
  38. Gregoriou O, Vitoratos N, Papadias C, et al. Treatment of idiopathic oligozoospermia with an alpha-blocker: a placebo-controlled double-blind trial. Int J Fertil Womens Med 1997;42:301-05.
  39. Palermo G, Alikani M, Bertoli M, et al. Oolemma characteristics in relation to survival and fertilization patterns of oocytes treated by intracytoplasmic sperm injection. Human Reproduction 1996;11:172-76.
  40. Tarlatzis BC, Bili H. Intracytoplasmic sperm injection. Survey of world results. Annals of the New York Academy of Sciences 2000;900:336-44.
  41. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2303&mid=1085056570&magid=173

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>